Genetics of uterine leiomyomata;Genetique des leiomyomes uterins

Bulletin du Cancer

Volumn 86, Issue 11, 1999, Pages 920-928

  Pedeutour, Florence ^a   Ligon, Azra H ^b   Morton, Cynthia C ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Benign tumors; Fibroids; Genetics; HMGIC; HMGIY; Uterine leiomyomata

Indexed keywords

BENIGN TUMOR; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME ABERRATION; ETHNOLOGY; FAMILIAL DISEASE; FEMALE; GENE DELETION; GENE DISRUPTION; GENETIC PREDISPOSITION; HUMAN; REVIEW; UTERUS MYOMA; AGE; CHROMOSOME DELETION; GENETICS; LEIOMYOMA; PATHOLOGY; UTERUS CANCER;

TUMOR PROTEIN;

AGE FACTORS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEIOMYOMA; NEOPLASM PROTEINS; UTERINE NEOPLASMS;

EID: 0033227295     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94: 435-8.
2. Nilbert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 1990; 2: 3-13.
3. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991; 77: 923-6.
4. Brosens I, Deprest J, Dal Cin P, Van den Berghe H. Clinical significance of cytogenetic abnormalities in uterine myomas. Fertil Steril 1998; 69: 232-5.
5. Rein MS, Powell WL, Walters FC, Weremowicz S, Canto RM, Barbieri RL, et al. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod 1998; 4: 83-6.
6. Ozisik YY, Meloni AM, Surti U, Sandberg AA. Deletion 7q22 in uterine leiomyomata. A cytogenetic review. Cancer Genet Cytogenet 1993; 23: 305-13.
7. Sargent MS, Weremowicz S, Rein MS, Morton CC. Translocations in 7q22 define a critical region in uterine leiomyomata. Cancer Genet Cytogenet 1994; 77: 65-8.
8. Tsui LC, Donis-Keller H, Grzeschik KH. Report of the second international workshop on human chromosome 7 mapping 1994. Cytogenet Cell Genet 1995; 71: 1-13.
9. Zeng WR, Scherer SW, Koutsilieris M, Huizenga JJ, Filteau F, Tsui LC, Nepveu A. Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas. Oncogene 1997; 14: 2355-65.
10. Quintana DG, Thome KC, Hou ZH, Ligon AH, Morton CC, Dutta A. ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases. J Biol Chem 1998; 273: 27137-45.
11. Mitelman F. Catalog of chromosome aberrations in cancer 98. Version 1 sur CD-Rom. New York: J. Wiley and Sons, 1998.
12. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82: 57-65.
13. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdick J, Van den Berghe H, Van de Ven WJM. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nature Genet 1995; 10: 436-44.
14. Schoenberg Fejzo M, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, et al. Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomas Cancer 1996; 17: 1-6.
15. Gattas GJ, Quade BJ, Nowak RA, Morton CC. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomas Cancer 1999; 254: 316-22.
16. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376: 771-4.
17. Kazmierczak B, Bol S, Wanschura S, Barnitzke S, Bullerdick B. PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes Chromosomas Cancer 1996; 17: 191-3.
18. Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, et al. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomas Cancer 1998; 23: 279-85.
19. Xiao S, Lux M, Reeves R, Hudson TJ, Fletcher JA. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol 1997; 150: 901-10.
20. Hess JL. Chromosomal translocations in benign tumors. The HMGI proteins. Am J Clin Pathol 1998; 109: 251-61.
21. Yie J, Merika M, Munshi N, Chen G, Thanos D. The role of HMGIY in the assembly and function of the IFN-b enhanceosome. EMBO J 1999; 18: 3074-89.
22. Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnizke S, Van de Ven WJM, et al. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 1995; 55: 6038-9.
23. Kazmierczak B, Pohnke Y, Bullerdick J. Fusion transcripts between the HMGIC gene and RTVL-H related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics 1996; 38: 223-6.
24. Schoenmakers EFPM, Huysmans C, Van de Ven WJM. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 1999; 59: 19-23.
25. Pedeutour F, Quade BJ, Weremowicz S, Dal Cin P, Ali S, Morton CC. Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata. Genes Chromosomas Cancer 1998; 23: 361-6.
26. Petit MMR, Mols R, Schoenmakers EFPM, Mandahl N, Van de Ven WJM. LPP, the preferred fusion partner gene of HMGI-C in lipomas, is a novel member of the LIM protein gene family. Genomics 1996; 36: 118-29.
27. Mashal RD, Schoenberg Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomas Cancer 1994; 11: 1-6.
28. Kjerulff KH, Langenberg PW, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996; 41: 483-90.
29. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation of the incidence of uterine leiomyomata among premenopausal women by age and race. Obstet Gynecol 1998; 90: 967-73.
30. Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gyn Obstet 1995; 51: 127-31.